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Commentary
A review of contemporary contraceptives
and sterilization techniques for feral horses
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Abstract: This commentary provides a brief review of the history of contraceptive

research eﬀorts for feral horses (Equus ferus caballus) as well as the contraceptives and
sterilization techniques currently available for feral horses. Porcine zona pellucida (PZP)
immunocontraceptives have received the most attention and use over the past 40 years,
but other treatments such as the GnRH vaccine Gonacon™-Equine are also available.
Optimization of these treatments as well as the development of other molecular approaches,
intrauterine devices, and surgical techniques is ongoing.
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Since the late ₁₉₇₀s, researchers have sought
a safe and eﬀective equine contraceptive to help
reduce population growth rates of feral horses
(Equus ferus caballus) and burros (E. asinus). A
good treatment that is safe, practical, eﬀective,
and long lasting has not yet been developed.
Even after a treatment is developed that is
eﬀective for individual animals, there remain
significant hurdles at the population level that
must be overcome to reduce population growth
rates (Garrott 2018).
Early fertility control eﬀorts focused on both
male and female contraception. However,
as early as 1980, scientists with the National
Research Council (NRC), part of the National
Academies of Science, recommended that wild
horse contraceptive eﬀorts focus on reducing
fertility in mares (NRC 1982). They recognized
the polygynandrous nature of feral horses
where multiple males may breed the same
or multiple females. While it is true that wild
horses live in harems that include a dominant
stallion, much of the breeding may also be
done by other stallions, and harem structures
are fluid over time. It has been demonstrated
that up to one third of foals may be sired by
stallions that are not aﬃliated with a mare’s
band (Bowling and Touchberry 1990).

While there was some success in mares, the
treatments were cumbersome to administer,
and there were concerns about the potential for
persistence of the hormones in the food chain
and the environment. About this same time,
studies were done with surgical vasectomies
applied to harem stallions. There was a small
eﬀect noted in 1 of the 2 groups studied, but
it was short lived. The researchers concluded
that, while it may be eﬀective at the individual
horse level, the eﬃcacy of vasectomizing males
for population growth suppression over time
was doubtful.
As attention turned away from using steroid
hormones to alter fertility, porcine zona
pellucida (PZP) vaccines were developed in
laboratory rodents and later applied to horses
(Liu et al. 1989, Kirkpatrick et al. 1992). The
PZP vaccine contains a glycoprotein antigen
harvested from pig (Sus scrofa domesticus)
ovaries. When mixed with a powerful adjuvant
(in most cases it is emulsified with Freund’s
adjuvant), it stimulates the mare’s immune
system to make antibodies to ZP proteins. These
antibodies block fertilization of the egg and over
time bind to zona proteins in the ovary causing
it to shrink and become nonfunctional. The
most widely used PZP vaccine is Zonastat-H®.
This liquid immunocontraceptive can be hand
Steroid hormones to vaccines
injected or darted into mares. When a booster
Early contraceptive studies in stallions and shot is also administered about 30 days later
mares used steroid hormones to alter fertility. and about 1–2 months prior to the breeding
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season, it is highly eﬀective at preventing
conception for 1 year, with only about 10–20%
of treated mares foaling each year. In smaller
herds where the number of animals is at or
very close to the desired population numbers,
or the Appropriate Management Level (AML),
Zonastat-H can successfully reduce or even
eliminate the need to gather and remove
animals over time.
The Bureau of Land Management (BLM) is
currently using this approach in several herds
(BLM 2017). The biggest limitation to this
treatment is that it must be administered every
year. Most animals on BLM ranges cannot be
approached closely enough to allow darting,
and repeated annual roundups to allow hand
injecting the treatment get more diﬃcult with
each repetition, usually becoming impractical
and ineﬀective after 2 or 3 iterations. Another
limitation of this approach is how long it takes
to achieve the AML when herds are even
modestly above the desired numbers. The
so-called Assateague prescription, where the
vast majority of mares was darted every year
(Kirkpatrick and Turner 2008), was eventually
eﬀective at achieving population targets on a
small barrier island, but it took 13 years before
a decline in numbers was achieved and several
additional years before AML was achieved.
That population of 156 horses started in 1993
only 30% over the desired AML of 120 horses,
had 143 horses after 13 years, and today has
about 90 horses. For comparison, many wild
horse herds managed by the BLM in the west
are currently at levels >100% greater than AML.
The quest for a longer-lasting PZP treatment
began about the same time that Zonastat-H was
being developed. An early study of the pelleted
“PZP-22” treatment was most promising with
only 6–18% of mares reported foaling in the
first 2 years of the Clan Alpine study (Turner
et al. 2007) and 30–40% foaling in years 3 and
4. Unfortunately, this level of success has never
been repeated, with several captive and freeranging trials reporting 25, 30, or even 70%
foaling in the first 2 years following treatment.
The reasons for this poor performance mostly
remain a mystery. Recently, success of 15–40%
foaling over a 3-year period was reported
with reformulated PZP-22 after additional
booster treatments (Rutberg et al. 2017), but
whether or not this can be repeated remains
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to be seen. Currently, PZP-22 is the treatment
used most frequently by the BLM; at the very
least, it usually provides 1 year of good eﬃcacy
without requiring a 30-day booster shot, and
when boostered 1–2 years later, eﬃcacy should
improve.
Spay Vac®, another formulation of PZP developed
to oﬀer longer-lasting eﬃcacy, uses similar PZP
antigens with a unique liposome technology
expected to provide several years of eﬃcacy. As
with PZP-22, an initial study of the treatment
was promising (Killian et al. 2008). However,
subsequent trials aimed at demonstrating longterm eﬃcacy in a captive pasture breeding
setting could not duplicate the same results
and in fact showed reasonable eﬃcacy in 1 year
(15% foaling) but poor eﬃcacy over time with
up to 70% of treated mares foaling (Roelle et al.
2017). Although this vaccine is not commercially
available at this time, the proponents of the
product have regrouped and hope to conduct
testing of a new formulation of Spay Vac in the
future (Bechert and Fraker 2018). Although this
product shares the same limitations inherent
to the PZP antigen as Zonastat-H and PZP22, in some species including occasionally
horses, it seems like it could be long-lasting or
even permanent. The reliability of the newly
formulated product will need to be established
in captive breeding trials with horses before
one might have the confidence needed for field
applications.

Gonacon
At this time, there is only 1 other
contraceptive product available for use in
horses. Gonacon™-Equine is a vaccine that
acts against gonadotropin releasing hormone
(GnRH), a hormone critical to fertility. The
vaccine was formulated and registered with the
Environmental Protection Agency as a 1-shot
treatment that was thought to provide good
multiyear eﬃcacy. Captive pen trials resulted
in good eﬃcacy (6% foaling) the first year
(Killian et al. 2008), but again the eﬃcacy of a
single treatment in field trials conducted with
feral horses at Theodore Roosevelt National
Park never reached that level of eﬀectiveness,
with about 50% of animals foaling the first and
second years (Baker et al. 2017). Fortunately,
with a booster treatment as much as 3 years
following the initial shot, eﬃcacy improved
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dramatically with 0% of mares foaling a year
later and around 15% foaling in the following 2
years. Like PZP vaccines, Gonacon can be hand
injected or darted. It has 2 advantages in that it
does not require mixing in the field and is more
stable when stored. The longer-term eﬃcacy of
Gonacon seems more promising than the PZP
vaccines at this time; however, optimal booster
schedules are still being investigated. The BLM
has used Gonacon in a small pilot project on the
range, and the early results are encouraging.
Gonacon treatment that includes a booster may
be among the best options currently available
for the contraception of feral horses.

Intrauterine devices
After many years of focusing primarily on PZP
and GnRH technologies, other contraceptive
approaches are now being investigated for
feral horses with support from the BLM (BLM
2017). In addition to injectable treatments, new
intrauterine devices (IUDs) are being tested.
Early studies of IUDs were promising, with
reports of >80% retention and eﬃcacy with
no negative eﬀects on mare health (Daels and
Hughes 1995). However, once again, when
additional captive breeding trials were done
with the same design (as well as other more
sophisticated designs promoted as eﬀective with
100% retention), the results were disappointing
with 60–100% of the devices falling out soon
after stallions were allowed to breed the mares.
A current BLM-supported study of a new IUD
has had some success with a redesigned product
that seems to oﬀer good retention in the presence
of stallions. Data are still being obtained at this
time to demonstrate retention, eﬃcacy, and
safety over a period of years. The IUDs have
the advantage of being almost 100% eﬀective as
long as they are retained. They appear to have
no long-term negative eﬀects on the mare’s
health or the uterus, and they could be 100%
reversible if removed. They do have the distinct
disadvantage that they can only be inserted into
non-pregnant mares, and most feral horse mares
of breeding age are pregnant for most of the
year.

Surgical sterilization
Surgical sterilization, once considered taboo
for feral horses because it is permanent, is also
again being considered as a means of reducing
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population growth rates. For stallions, the
same limitations of polygynandry that became
apparent back in the 1980s are still present. It
seems unlikely that castrating or vasectomizing
only some portion of the more dominant males
in a herd will significantly slow population
growth over a period of several years,
because enough stallions will still be present
to eventually breed all the mares present.
However, a saturation approach where some
high percentage (e.g., 80–95%) of stallions are
sterilized remains untested.
In their most recent review of the science
behind feral horse contraception, the National
Academy of Sciences recommended chemical
vasectomy as a promising technique (NRC
2013). Despite acknowledging that it was not yet
proven, they felt that it should not be diﬃcult
to adapt to feral horses. Unfortunately, this
doesn’t seem to be the case. When chemically
vasectomized horses were reexamined after
a recent study performed on the Sheldon
Wildlife Refuge (Collins and Kasbohm 2016),
it was revealed that the chemical vasectomies
failed to block sperm transport in any of the
dozens of animals treated (Scully et al. 2015).
While it should be possible to develop and
use a technique for chemical vasectomy,
it seems to oﬀer little advantage over the
surgical procedure, which has been done with
individual horses but remains unproven at the
population level. The fact that a small number
of fertile stallions can impregnate many mares
suggests that any form of vasectomy is unlikely
to be an eﬀective means of long-term population
growth suppression.
The consideration of surgical sterilization
is not limited to stallions but also extends to
spaying and tubal ligation procedures for
mares. There is no established procedure for
tubal ligation in mares. It just is not something
that is called for among domestic horses and
has not been developed or tested for feral
horses. Spaying, while not as common as
castration, is done in domestic horses and has
been done with feral horses. The procedure in
horses is much more diﬃcult than it is in cattle
and not as routinely practiced as spaying dogs
and cats, for example. It is almost never done
to pregnant domestic horses, so the safety and
practicality of spaying feral horses on a large
scale, particularly while pregnant, remains
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mostly untested.
Feral mares were spayed on the Sheldon
Wildlife Refuge with a report of fewer foals
born to harems that included spayed mares and
vasectomized stallions (Collins and Kasbohm
2016), but it remains to be seen if similar results
could be obtained in other places when spaying
is done on a large scale in the context of typical
BLM roundups. Yes, individual mares can be
spayed, but can practitioners do it safely on
a large scale with pregnant mares, and will it
help achieve the goal of controlling population
growth rates? The BLM has attempted to answer
some of these questions with applied research,
but these questions remain unanswered largely
due to litigation that prevented the projects
from getting started.

What is the ideal contraceptive?
We are often asked, why hasn’t anyone
developed the ideal contraceptive for feral
horses when the BLM has been supporting this
research for >40 years? The answer is perhaps
that an ideal contraceptive is an unreasonable
expectation for any species. Safety for mares,
unborn colts, and the environment are
paramount, but is it really reasonable to expect
a 1-shot, long-lasting, predictably reversible
contraceptive that has no behavioral eﬀects for
horses when modern science has never even
developed such a treatment for dogs, cats, or
people? The emphasis for reproductive research
in the domestic horse world has always been
getting mares pregnant, not trying to prevent
pregnancy. Until the last few years, there has
been very limited funding for contraceptive
research for horses with more funding obligated
by the BLM to research projects in the last few
years than the previous 40 years combined. From
where we started in the 1970s, researchers have
made significant discoveries and improvements
in contraceptives for feral horses.
The desperate need for results in the field
and the limited funding available have meant
that several treatments were advanced to field
trials or management use in the field after
only 1 test under more limited conditions. It
is not uncommon for treatments that work in
controlled laboratory or clinical settings not to
work as well when applied on a larger scale in
the field. Unfortunately, we have seen this with
feral horse contraception on several occasions.

Human–Wildlife Interactions 12(1)
Were the early studies flawed by unblinded,
biased outcome assessments? What about the
blinded (Spay Vac) studies that also could not
be replicated? Was it the biological variation
in the PZP itself, changes in the adjuvants or
preparation of the vaccines? All of these factors
are the reason that research science prefers
to look for replication of results by diﬀerent
investigators under expanded conditions before
taking treatments to management application
in the field. However, these are luxuries that
feral horse contraceptive research didn’t have.
The pressure and the push have been to
take treatments to the field as soon as they
oﬀer some legitimate promise of success.
The upside would have been faster results
where they were needed most. The downside
was several treatments didn’t work as well
as expected when applied on a large scale.
These challenges were added to the practical
limitations and expectations of trying to apply
darting programs to the typically vast western
rangelands that span not thousands of acres
but hundreds of thousands of acres. Darting
programs can work on a small scale where
100 or so named animals can be approached to
within 30 or 40 yards. However, where 10 times
as many horses might roam on land areas 30
times larger and the horses can’t be recognized
as individuals because they mostly look alike,
this approach is not practicable. Most often
these animals can’t be approached to less than
hundreds of yards. Under these more typical
conditions, darting programs aren’t likely to
succeed. Despite all this, there have been smallscale successes on some BLM lands: the Pryor
Mountains Wild Horse Range and the Little
Book Cliﬀs, McCullough Peaks, and Spring
Creek Basin Herd Management Areas come to
mind.

Conclusion
The history of feral horse contraception
research is one of desperate need, ambitious
(perhaps sometimes unreasonable) goals,
and the passionate pursuit of a solution by a
handful of investigators challenged by limited
resources as well as the biology of the endeavor.
Unfortunately, today, despite the many advances
that have been made, a contraceptive solution
that is safe, practical, and eﬀective for most
herds on typical western herds is not in hand.
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Right now, feral horse contraception research
has better levels of funding than ever before,
with major universities more engaged than ever
and new, never previously conceived molecular
techniques being investigated. Nevertheless,
progress will likely be slow. For every idea that
advances to the next level of investigation 2 or
3 others will fail. Despite the desperate need, if
we can maintain current research funding levels,
we are years or likely more than a decade away
from a contraceptive solution to the challenge
of significantly reducing feral horse population
growth rates on western rangelands. The good
news is that it is still conceivable, and there are
still some very bright and passionate scientists
working on solutions that will make a diﬀerence.

Acknowledgments
The author is grateful to B. Roelle and P.
Griﬃn for their assistance in preparing this
commentary. The information, ideas, and
opinions expressed are those of the author
and do not necessarily represent those of the
U.S. Department of Agriculture or the U.S.
Department of Interior, or endorsement of
the product herein. Comments provided by 2
anonymous reviewers greatly improved the
manuscript.

Literature cited
Baker, D., J. Powers, J. Ransom, B. McCann,
M. Oehler, J. Bruemmer, N. Galloway, D. Eckery, and T. Nett. 2017. Gonadotropin-releasing
hormone vaccine (GonaCon-Equine) suppresses fertility in free-ranging horses (Equus
caballus): limitations and side eﬀects of treatment. Proceedings of the 8th International
Conference on Wildlife Fertility Control 8:12.
Bechert, U. S., and M. A. Fraker. 2018. Twenty years
of SpayVac® research: potential implications for
regulating feral horse and burro populations in
the United States. Human–Wildlife Interactions
12:117–130.
Bowling, A. T., and R. W. Touchberry. 1990.
Parentage of Great Basin feral horses. Journal
of Wildlife Management 54:424–429.
Bureau of Land Management (BLM). 2017. Wild
horse and burro: science and research. U.S. Department of the Interior, Washington, D.C., USA,
<https://www.blm.gov/programs/wild-horseand-burro/herd-management/science-and-research>. Accessed February 21, 2018.

115

Collins, G. H., and J. W. Kasbohm. 2016. Population dynamics and fertility control of feral horses.
Journal of Wildlife Management 81:289–296.
Daels, P. F., and J. P. Hughes. 1995. Fertility control using intrauterine devices: an alternative
for population control in wild horses. Theriogenology 44:629–639.
Garrott, R. A. 2018. Wild horse demography:
implications for sustainable management within economic constraints. Human–Wildlife Interactions 12:46–57.
Killian, G., D. Thain, N. K. Diehl, J. Rhyan, and L.
Miller. 2008. Four-year contraception rates of
mares treated with single injection porcine zona
pellucida and GnRH vaccines and intrauterine
devices. Wildlife Research 35:531–539.
Kirkpatrick, J. F., I. M. K. Liu, J. W. Turner, R. Naugle,
and R. Keiper. 1992. Long-term eﬀects of porcine zonae pellucidae immunocontraception on
ovarian function in feral horses (Equus caballus).
Journal of Reproduction and Fertility 94:437–444.
Kirkpatrick, J. F., and A. Turner. 2008. Achieving
population goals in a long-lived wildlife species
(Equus caballus) with contraception. Wildlife
Research 35:513–519.
Liu, I. K. M., M. Bernoco, and M. Feldman. 1989.
Contraception in mares heteroimmunized with
pig zonae pellucidae. Journal of Reproduction
and Fertility 85:19–29.
National Research Council. 1982. Wild and freeroaming horses and burros: ﬁnal report. National Academies Press, Washington, D.C., USA.
National Research Council. 2003. Using science
to improve the BLM Wild Horse and Burro
Program: a way forward. National Academies
Press, Washington, D.C., USA.
Roelle, J. E., S. S. Germaine, A. J. Kane, and B. S.
Cade. 2017. Eﬃcacy of SpayVac® as a contraceptive in feral horses. Wildlife Society Bulletin
41:107–115.
Rutberg, A., K. Grams, J. W. Turner, and H.
Hopkins. 2017. Contraceptive eﬃcacy of priming and boosting does of controlled-release
PZP in wild horses. Wildlife Research 44:174–
181.
Scully, C. M., R. L. Lee, L. Pielstick, J. Medlock,
K. M. Patton, G. H. Collins, and M. A. Kutzler.
2015. Comparison of chemical and surgical vasectomy on testicular activity in free-roaming
horses (Equus caballus). Journal of Zoo and
Wildlife Medicine 46:815–824.
Turner, J. W., I. K. Liu, D. R. Flanagan, A. T. Rutberg,

116
and J. F. Kirkpatrick. 2007. Immunocontraception in wild horses: one inoculation provides two
years of infertility. Journal of Wildlife Management 71:662–667.
Associate Editor: Terry A. Messmer

A˕ˋˎ˛˝ J. Kˊ˗ˎ is a veterinary epide-

miologist who works for the U.S. Department of
Agriculture, APHIS: Veterinary
Services. He is located in
Ft. Collins, Colorado, where
he serves as a senior staﬀ
veterinarian for the USDA and
an advisor for the APHIS/BLM
Wild Horse and Burro (WHB)
Partnership. He manages
the partnership between the
agencies, serves as the WHB
program’s staﬀ veterinarian,
and assists with BLM ﬁeld operations. For the past 17 years,
he has consulted with the BLM on matters related to
animal health and handling and serves on the BLM’s
National Wild Horse and Burro Research Advisory
and Comprehensive Animal Welfare Teams.

Human–Wildlife Interactions 12(1)

